IP Library Granted Patent US 8,921,052
Granted Patent B2
US 8,921,052 · App. 11/918,394 · Granted Dec 30, 2014

Hemoglobin derivative measurement method, and reagent composition, measurement kit, analysis device and analysis system for use in the method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,921,052
App. No.
11/918,394
Granted
Dec 30, 2014
Kind
B2
Abstract

A sample solution including blood components is processed with a denaturalization reagent comprising a nonionic surface-activating agent and an oxidizing agent to denaturalize a hemoglobin derivative in the sample solution, and thereafter, an immunoassay is performing utilizing an antibody that is specific to a denaturalized site of the hemoglobin derivative to measure the amount of the hemoglobin derivative in the sample. Therefore, when performing assay of hemoglobin derivative, denaturalization of hemoglobin can be performed speedily and reliably while minimizing adverse effects of the denaturalization reagent on immune reaction.

Claims (20)

1. A hemoglobin derivative measurement method comprising:

processing a sample which comprises blood components including erythrocytes, with a reagent composition comprising:

an oxidizing agent, and

a nonionic surface-activating agent selected from the group consisting of n-Decyl-β-D-maltoside, n-Nonyl-β-D-thiomaltoside, Sucrose monocaprate, and Sucrose monolaurate,

whereby the combination of said nonionic surface-activating agent with the oxidizing agent denaturalizes a hemoglobin derivative from the erythrocytes in the sample; and

detecting the denatured hemoglobin derivative in the sample by performing an immunoassay using an antibody that is specific to a denaturalized site of the hemoglobin derivative.

2. A hemoglobin derivative measurement method as defined in claim 1 wherein said hemoglobin derivative is glycated hemoglobin, and said antibody is specific to a denaturalized site of the glycated hemoglobin.

3. A hemoglobin derivative measurement method as defined in claim 1 further including measuring the hemoglobin included in the sample, and calculating an abundance ratio of the hemoglobin derivative to the hemoglobin.

4. A hemoglobin derivative measurement method as defined in claim 3 wherein said hemoglobin derivative is glycated hemoglobin.

5. A reagent composition for measuring a hemoglobin derivative in a sample which comprises blood components including erythrocytes, said reagent composition comprising:

a nonionic surface-activating agent selected from the group consisting of n-Decyl-β-D-maltoside, n-Nonyl-β-D-thiomaltoside, Sucrose monocaprate, and Sucrose monolaurate;

an oxidizing agent; and

an antibody that is specific to a denaturalized site of the hemoglobin derivative from the erythrocytes.

6. A reagent composition as defined in claim 5 wherein said hemoglobin derivative is glycated hemoglobin, and said antibody is specific to a denaturalized site of the glycated hemoglobin.

7. A measurement kit for measuring a hemoglobin derivative in a sample which comprises blood components including erythrocytes, said measurement kit holding:

a reagent composition comprising:

a nonionic surface-activating agent selected from the group consisting of n-Decyl-β-D-maltoside, n-Nonyl-β-D-thiomaltoside, Sucrose monocaprate, and Sucrose monolaurate; and

an oxidizing agent;

and an antibody that is specific to a denaturalized site of a hemoglobin derivative from the erythrocytes.

8. A measurement kit as defined in claim 7 wherein said hemoglobin derivative is glycated hemoglobin, and said antibody is specific to a denaturalized site of the glycated hemoglobin.

Assignments (5)
CHANGE OF NAME Recorded Jun 29, 2018
From: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
To: PHC HOLDINGS CORPORATION
Reel/Frame 046459/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2015
From: PANASONIC HEALTHCARE CO., LTD.
To: PANASONIC HEALTHCARE HOLDINGS CO., LTD.
Reel/Frame 035268/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2014
From: PANASONIC CORPORATION
To: PANASONIC HEALTHCARE CO., LTD.
Reel/Frame 032360/0795 →
CHANGE OF NAME Recorded Nov 3, 2008
From: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
To: PANASONIC CORPORATION
Reel/Frame 021779/0851 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2008
From: TANAKA, HIROTAKA; TANAKA, MASANORI; KITAWAKI, FUMIHISA
To: MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD.
Reel/Frame 020404/0778 →